Yahoo Web Search

  1. Is Amgen, Inc. (AMGN) A Good Stock To Buy?

    Insider Monkey via Yahoo FinanceJun 06 21:59 PM

    In this article, we take a closer look at Amgen, Inc. (NASDAQ:AMGN) from the perspective of those elite funds. Hedge fund interest in Amgen, Inc. (NASDAQ:AMGN) shares ...

  2. Should We Be Delighted With Amgen Inc.'s (NASDAQ:AMGN) ROE Of 75%?

    Simply Wall St. via Yahoo FinanceJun 06 18:30 PM

    By way of learning-by-doing, we'll look at ROE to gain a better understanding of Amgen Inc. (NASDAQ:AMGN). Over the last twelve months Amgen has recorded a ROE of 75%. How ...

  3. This could indicate that investors who seek to profit from falling equity prices are not currently targeting AMGN.

  4. In the phase I study, AMG 510, when given as a monotherapy, showed encouraging anti-tumor activity in patients with locally-advanced or metastatic KRASG12C mutant solid tumors The study enrolled ...

  5. A month has gone by since the last earnings report for Amgen (AMGN). Amgen reported first-quarter 2019 earnings of $3.56 per share, which beat the Zacks Consensus Estimate of $3.45 ...

  6. Adverum Biotechnologies Inc (NASDAQ: ADVM) Array Biopharma Inc (NASDAQ: ARRY) Ascendis Pharma A/S (NASDAQ: ASND) Mirati Therapeutics Inc (NASDAQ: MRTX)(reacted to ASCO presentation ...

  7. Iovance and Amgen Are Making Cancer History

    Bloomberg via Yahoo FinanceJun 05 12:00 PM

    Amgen shares climbed more than 4 percent this week, while Mirati Therapeteutics Inc. – a smaller rival that’s working on a similar lung cancer drug to Amgen’s surged more ...

  8. Amgen (AMGN) closed the most recent trading day at $166.70, moving -1.38% from the previous trading session. Heading into today, shares of the world's largest biotech drugmaker had lost ...

  9. An analyst at Citigroup looked into why Mirati's NSCLC candidate has the potential to outdo Amgen's. Yigal Nochomovitz upgraded Mirati from Neutral to Buy and increased the price target ...

  10. This has outpaced the Medical sector's loss of 1.29% and the S&P 500's loss of 3.77% in that time. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.66 billion ...

  1. Ads
    related to Amgen Inc